Chiari Malformation Type 2  >>  moxifloxacin intravenous  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
moxifloxacin intravenous / Generic mfg.
NCT00292227: Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Completed
1
130
RoW
Rotigotine, Neupro, Placebo, Moxifloxacin infusion, Placebo infusion
UCB Pharma
Parkinson's Disease
09/06
10/06

Download Options